|
1
|
GBD 2013 Mortality and Causes of Death
Collaborators: Global, regional, and national age-sex specific
all-cause and cause-specific mortality for 240 causes of death,
1990–2013: A systematic analysis for the Global Burden of Disease
Study 2013. Lancet. 385:117–171. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vander Heiden MG, Cantley LC and Thompson
CB: Understanding the Warburg effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Johnson C, Warmoes MO, Shen X and Locasale
JW: Epigenetics and cancer metabolism. Cancer Lett. 356:309–314.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cairns RA, Harris IS and Mak TW:
Regulation of cancer cell metabolism. Nat Rev Cancer. 11:85–95.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Phang JM and Liu W: Proline metabolism and
cancer. Front Biosci (Landmark Ed). 17:1835–1845. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Phang JM, Liu W, Hancock CN and Fischer
JW: Proline metabolism and cancer: Emerging links to glutamine and
collagen. Curr Opin Clin Nutr Metab Care. 18:71–77. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Maxwell SA and Davis GE: Differential gene
expression in p53-mediated apoptosis-resistant vs.
Apoptosis-sensitive tumor cell lines. Proc Natl Acad Sci USA.
97:pp. 13009–13014. 2000; View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Maxwell SA and Rivera A: Proline oxidase
induces apoptosis in tumor cells, and its expression is frequently
absent or reduced in renal carcinomas. J Biol Chem. 278:9784–9789.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu W and Phang JM: Proline dehydrogenase
(oxidase) in cancer. Biofactors. 38:398–406. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guernsey DL, Jiang H, Evans SC, Ferguson
M, Matsuoka M, Nightingale M, Rideout AL, Provost S, Bedard K, Orr
A, et al: Mutation in pyrroline-5-carboxylate reductase 1 gene in
families with cutis laxa type 2. Am J Hum Genet. 85:120–129. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Possemato R, Marks KM, Shaul YD, Pacold
ME, Kim D, Birsoy K, Sethumadhavan S, Woo HK, Jang HG, Jha AK, et
al: Functional genomics reveal that the serine synthesis pathway is
essential in breast cancer. Nature. 476:346–350. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rhodes DR, Yu J, Shanker K, Deshpande N,
Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM:
ONCOMINE: A cancer microarray database and integrated data-mining
platform. Neoplasia. 6:1–6. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fang Y, Fu D, Tang W, Cai Y, Ma D, Wang H,
Xue R, Liu T, Huang X, Dong L, et al: Ubiquitin C-terminal
Hydrolase 37, a novel predictor for hepatocellular carcinoma
recurrence, promotes cell migration and invasion via interacting
and deubiquitinating PRP19. Biochim Biophys Acta. 1833:559–572.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jariwala U, Prescott J, Jia L, Barski A,
Pregizer S, Cogan JP, Arasheben A, Tilley WD, Scher HI, Gerald WL,
et al: Identification of novel androgen receptor target genes in
prostate cancer. Mol Cancer. 6:392007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Musgrove EA: Cyclins: Roles in mitogenic
signaling and oncogenic transformation. Growth Factors. 24:13–19.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
De Ingeniis J, Kazanov MD, Shatalin K,
Gelfand MS, Osterman AL and Sorci L: Glutamine versus ammonia
utilization in the NAD synthetase family. PLoS One. 7:e391152012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mohamed A, Deng X, Khuri FR and Owonikoko
TK: Altered glutamine metabolism and therapeutic opportunities for
lung cancer. Clin Lung Cancer. 15:7–15. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
De Ingeniis J, Ratnikov B, Richardson AD,
Scott DA, Aza-Blanc P, De SK, Kazanov M, Pellecchia M, Ronai Z,
Osterman AL and Smith JW: Functional specialization in proline
biosynthesis of melanoma. PLoS One. 7:e451902012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ernst T, Hergenhahn M, Kenzelmann M, Cohen
CD, Bonrouhi M, Weninger A, Klären R, Gröne EF, Wiesel M, Güdemann
C, et al: Decrease and gain of gene expression are equally
discriminatory markers for prostate carcinoma: A gene expression
analysis on total and microdissected prostate tissue. Am J Pathol.
160:2169–2180. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu W, Hancock CN, Fischer JW, Harman M
and Phang JM: Proline biosynthesis augments tumor cell growth and
aerobic glycolysis: Involvement of pyridine nucleotides. Sci Rep.
5:172062015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bretones G, Delgado MD and Leon J: Myc and
cell cycle control. Biochim Biophys Acta. 1849:506–516. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
McMahon SB: MYC and the control of
apoptosis. Cold Spring Harb Perspect Med. 4:a0144072014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Morrish F and Hockenbery D: MYC and
mitochondrial biogenesis. Cold Spring Harb Perspect Med. 4:pii:
a0142252014. View Article : Google Scholar
|
|
27
|
Liu W, Le A, Hancock C, Lane AN, Dang CV,
Fan TW and Phang JM: Reprogramming of proline and glutamine
metabolism contributes to the proliferative and metabolic responses
regulated by oncogenic transcription factor c-MYC. Proc Natl Acad
Sci USA. 109:pp. 8983–8988. 2012; View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kato JY, Matsuoka M, Strom DK and Sherr
CJ: Regulation of cyclin D-dependent kinase 4 (cdk4) by
cdk4-activating kinase. Mol Cell Biol. 14:2713–2721. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Han EK, Ng SC, Arber N, Begemann M and
Weinstein IB: Roles of cyclin D1 and related genes in growth
inhibition, senescence and apoptosis. Apoptosis. 4:213–219. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gautschi O, Ratschiller D, Gugger M,
Betticher DC and Heighway J: Cyclin D1 in non-small cell lung
cancer: A key driver of malignant transformation. Lung Cancer.
55:1–14. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Biliran H Jr, Wang Y, Banerjee S, Xu H,
Heng H, Thakur A, Bollig A, Sarkar FH and Liao JD: Overexpression
of cyclin D1 promotes tumor cell growth and confers resistance to
cisplatin-mediated apoptosis in an elastase-myc
transgene-expressing pancreatic tumor cell line. Clin Cancer Res.
11:6075–6086. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Adams JM and Cory S: The Bcl-2 protein
family: Arbiters of cell survival. Science. 281:1322–1326. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Anagnostou VK, Lowery FJ, Zolota V,
Tzelepi V, Gopinath A, Liceaga C, Panagopoulos N, Frangia K, Tanoue
L, Boffa D, et al: High expression of BCL-2 predicts favorable
outcome in non-small cell lung cancer patients with non squamous
histology. BMC Cancer. 10:1862010. View Article : Google Scholar : PubMed/NCBI
|
